Roxithromycin-d7

Roxithromycin-d7

• UNSPSC Description: Roxithromycin-d7 (RU-28965-d7) is the deuterium labeled Roxithromycin (HY-B0435)[1]. Roxithromycin (RU-28965) is a semi-synthetic macrolide antibiotic[2].
• Target Antigen: Antibiotic; Bacterial; Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Anti-infection;Others
• Field of Research: Others
• Purity: 98.28
• Solubility: 10 mM in DMSO
• Smiles: C[C@H]([C@H]([C@](O)(C[C@H](/C([C@@H]([C@H]([C@](O)([C@H](OC([C@@H]1C)=O)CC)C)O)C)=N\OCOC([2H])([2H])C([2H])([2H])OC([2H])([2H])[2H])C)C)O[C@H]2[C@@H]([C@H](C[C@H](O2)C)N(C)C)O)[C@@H]1O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)O)OC
• Molecular Weight: 844.09
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: No Development Reported